Farmaco-epidemiologie
Novel methodologies for causal research with real world data
- Universiteit Rijksuniversiteit Groningen
- Promovendus Ali Alghamdi
- Promoters E. Hak
- Co-Promoters M.J. Bijlsma
- Jaar 2022-2026
KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn19resultaten gevonden
Farmaco-epidemiologie
Towards personalized primary prevention of cerebroand cardiovascular diseases: observational studies based on the real-world data of 167,000 participants in the Netherlands
- Universiteit Rijksuniversiteit Groningen
- Promovendus Xuechun Li
- Promoters E. Hak
- Co-Promoters S. Mubarik
- Jaar 2021-2025
Farmaco-epidemiologie
RCT or RWE? Investigating standards that RWE needs to meet to supplement evidence from RCTs - building a framework
- Universiteit Rijksuniversiteit Groningen
- Promovendus Stefan Verweij
- Promoters E. Hak P.G.M. Mol
- Co-Promoters M.J. Bijlsma K. Oude Rengerink
- Jaar 2022-2027
Farmaco-epidemiologie
Estimating the scale of immunity gaps towards Measles and Rubella elimination: Case studies and epidemiological profile of Nigeria
- Universiteit Rijksuniversiteit Groningen
- Promovendus A.E. Jean Baptiste
- Promoters E. Hak E.A. Sanders
- Co-Promoters S.J.M. Hahne
- Jaar 2019-2022
Productzorg en bereiding
Drug shortages: causes and solutions
- Universiteit Radboud UMC Nijmegen
- Promovendus Nicky Cornelissen
- Promoters Bart van den Bemt, Patricia van den Bemt
- Co-Promoters Sander Zielhuis
- Jaar 2019-2025
Productzorg en bereiding
3D-printing of peadiatric medication
- Universiteit Erasmus Medisch Centrum Rotterdam
- Promovendus Amanda Holst
- Promoters P.H.M. (Hugo) van der Kuy
- Co-Promoters E.J. (Liesbeth) Ruijgrok
- Jaar 2024-2028
The aim of this project is to explore the 3D printing of peadiatric medicines. 3D printing technology enables the creation of medications with a wide range of dosages, shapes, flavors, and drug combinations, all customized to meet the unique needs of individual patients and specific disease conditions. Once the optimal formulations have been developed, the 3D printed medicines will undergo clinical trials for testing.
Productzorg en bereiding
3D-printing of peadiatric medication
- Universiteit Erasmus Medisch Centrum Rotterdam
- Promovendus Eveline van Kampen
- Promoters P.H.M. (Hugo) van der Kuy
- Co-Promoters E.J. (Liesbeth) Ruijgrok
- Jaar 2021-2026
We will study compounding medication by 3D printing technology. In this way personalized medication will become more accessable.
First formulation studies will be executed in order to provide a stable production process. After which, the use of 3D printing will be introduced in the clinical setting. Finally, the printed medication will be tested by a clinical trial.
Pagina 1 van 3